Research startup Care Access lays off half of staff following Pfizer Lyme trial woes
Contract research startup Care Access has let go about half of its employees in a major restructuring, two months after the company was removed from a huge Pfizer study of a Lyme disease vaccine.
The cuts amount to hundreds of people, and will affect nearly every part of the business. Employees were informed yesterday at a town hall. Care Access is part of Reify Health, a startup that was founded to reinvent clinical trials and has raised nearly half a billion dollars.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
